Intrinsic Value of S&P & Nasdaq Contact Us

Tactile Systems Technology, Inc. TCMD NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
73/100
4/7 Pass
SharesGrow Intrinsic Value
$166.07
+562.7%
Analyst Price Target
$38.75
+54.6%

Tactile Systems Technology, Inc. (TCMD) is a Medical - Devices company in the Healthcare sector, currently trading at $25.06. It has a SharesGrow Score of 73/100, indicating a above average investment profile with 4 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of TCMD = $166.07 (+562.7% from the current price, the stock appears undervalued). Analyst consensus target is TCMD = $39 (+54.6% upside).

Valuation: TCMD trades at a trailing Price-to-Earnings (P/E) of 28.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.03.

Financials: revenue is $330M, +10.1%/yr average growth. Net income is $19M, growing at +77.2%/yr. Net profit margin is 5.8% (thin). Gross margin is 75.2% (+3.9 pp trend).

Balance sheet: total debt is $16M against $219M equity (Debt-to-Equity (D/E) ratio 0.07, conservative). Current ratio is 4.03 (strong liquidity). Debt-to-assets is 5.8%. Total assets: $274M.

Analyst outlook: 7 / 11 analysts rate TCMD as buy (64%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 67/100 (Pass), Growth 90/100 (Pass), Past 75/100 (Partial), Health 100/100 (Pass), Moat 64/100 (Partial), Future 73/100 (Pass), Income 45/100 (Partial).

$38.75
▲ 54.63% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Tactile Systems Technology, Inc., the average price target is $38.75, with a high forecast of $42.00, and a low forecast of $35.00.
Highest Price Target
$42.00
Average Price Target
$38.75
Lowest Price Target
$35.00

TCMD SharesGrow Score Overview

73/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 67/100
Valuation — P/E, PEG, Forward PEG
GROWTH 90/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 64/100
Gross margin is + market cap
FUTURE 73/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — TCMD

VALUE Pass
67/100
TCMD trades at a trailing Price-to-Earnings (P/E) of 28.1 (S&P 500 average ~25). Forward PEG 1.03 — ~moderate (~1.5). Trailing PEG 3.13. Analyst consensus target is $39, implying +55.6% from the current price $25. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
90/100
TCMD: +10.1%/yr revenue is, +77.2%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
TCMD: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet TCMD: Debt-to-Equity (D/E) ratio 0.07 (conservative), Current ratio is 4.03 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
64/100
TCMD: Gross margin is 75.2% (+3.9 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 64/100. ≥ 70 = Pass.
View details →
FUTURE Pass
73/100
Analyst outlook: 7 / 11 analysts rate TCMD as buy (64%). Analyst consensus target is $39 (+55.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
45/100
TCMD: Net profit margin is 5.8%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range8.61-37.77
Volume268.47K
Avg Volume (30D)327.86K
Market Cap$570.13M
Beta (1Y)0.99
Share Statistics
EPS (TTM)0.83
Shares Outstanding$22.87M
IPO Date2016-07-28
Employees1,037
CEOSheri Louise Dodd
Financial Highlights & Ratios
Revenue (TTM)$329.52M
Gross Profit$247.7M
EBITDA$35.92M
Net Income$19.09M
Operating Income$29.28M
Total Cash$83.45M
Total Debt$15.96M
Net Debt$-67.49M
Total Assets$273.94M
Price / Earnings (P/E)30.2
Price / Sales (P/S)1.73
Analyst Forecast
1Y Price Target$39.00
Target High$42.00
Target Low$35.00
Upside+55.6%
Rating ConsensusBuy
Analysts Covering11
Buy 64% Hold 18% Sell 18%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS87357P1003

Price Chart

TCMD
Tactile Systems Technology, Inc.  ·  NASDAQ Global Market
Healthcare • Medical - Devices
8.61 52WK RANGE 37.77
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message